Great portrait of our Head of Research & Development and CMO, Dr. Ingrid Rauter. Ingrid talks…
Please read an article on the adjuvant treatment options in Renal Cell Carcinoma. This summary…
On Friday, 13.10.2023, Vaccentis held an Investor Meeting in Zürich. Prof. Martin Marszalek, Department Head for…
Vaccentis AG,
Gerechtigkeitsgasse 25, CH - 8001 Zürich
